Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn E Kuhmann

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Annual Review of Pharmacology and Toxicology|October 17, 2007
Targeting chemokine receptors in HIV: a status reportShawn E Kuhmann, Oliver Hartley
Virology|December 15, 2006
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entryPavel Pugach, Andre J Marozsan, Thomas J Ketas, et al.
Plos Pathogens|June 5, 2007
Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness lossCleo G Anastassopoulou, Andre J Marozsan, Alexandre Matet, et al.
Virology|April 13, 2007
Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligandsThomas J Ketas, Shawn E Kuhmann, Ashley Palmer, et al.
Virology|June 7, 2005
Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)Andre J Marozsan, Shawn E Kuhmann, Thomas Morgan, et al.
Virology|March 23, 2004
The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4Pavel Pugach, Shawn E Kuhmann, Joann Taylor, et al.
Journal of Virology|March 30, 2004
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitorsErika Billick, Christoph Seibert, Pavel Pugach, et al.
Journal of Virology|March 3, 2004
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitorShawn E Kuhmann, Pavel Pugach, Kevin J Kunstman, et al.
Virology|February 24, 2006
Interaction of small molecule inhibitors of HIV-1 entry with CCR5Christoph Seibert, Weiwen Ying, Svetlana Gavrilov, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 useAlexandra Trkola, Shawn E Kuhmann, Julie M Strizki, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annual Review of Pharmacology and Toxicology|October 17, 2007
Targeting chemokine receptors in HIV: a status reportShawn E Kuhmann, Oliver Hartley
Virology|December 15, 2006
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entryPavel Pugach, Andre J Marozsan, Thomas J Ketas, et al.
Plos Pathogens|June 5, 2007
Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness lossCleo G Anastassopoulou, Andre J Marozsan, Alexandre Matet, et al.
Virology|April 13, 2007
Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligandsThomas J Ketas, Shawn E Kuhmann, Ashley Palmer, et al.
Virology|June 7, 2005
Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)Andre J Marozsan, Shawn E Kuhmann, Thomas Morgan, et al.
Virology|March 23, 2004
The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4Pavel Pugach, Shawn E Kuhmann, Joann Taylor, et al.
Journal of Virology|March 30, 2004
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitorsErika Billick, Christoph Seibert, Pavel Pugach, et al.
Journal of Virology|March 3, 2004
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitorShawn E Kuhmann, Pavel Pugach, Kevin J Kunstman, et al.
Virology|February 24, 2006
Interaction of small molecule inhibitors of HIV-1 entry with CCR5Christoph Seibert, Weiwen Ying, Svetlana Gavrilov, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 useAlexandra Trkola, Shawn E Kuhmann, Julie M Strizki, et al.
Pageof 2